MITF
MITF (melanocyte inducing transcription factor, also known as microphthalmia-associated transcription factor, MI, bHLHe32, WS2A and WS2) is a basic helix-loop-helix leucine zipper transcription factor. It acts as a master regulator of melanocyte survival, differentiation and melanosome biogenesis. Browse Assay Genie's current range of MITF research reagents below, or read on for the biology behind the target.
MITF is a transcription factor that binds M-boxes (5'-TCATGTG-3') and symmetrical E-box sequences (5'-CACGTG-3') in the promoters of pigmentation genes, such as tyrosinase (TYR). By regulating TYR and tyrosinase-related protein 1 (TYRP1), it plays an important role in melanocyte development. It is described as a master regulator of melanocyte survival and differentiation as well as melanosome biogenesis, and it is also critical for the differentiation of other cell types, including neural crest-derived melanocytes, mast cells, osteoclasts and optic cup-derived retinal pigment epithelium.
MITF also participates in the cellular response to amino acid availability, acting downstream of MTOR. When nutrients are present, phosphorylation of MITF by MTOR promotes its inactivation. On starvation or lysosomal stress, inhibition of MTOR leads to MITF dephosphorylation, and the transcription factor becomes active. Consistent with this regulation, UniProt records the protein in the nucleus, the cytoplasm and the lysosome membrane.
The MITF gene encodes a protein with both basic helix-loop-helix and leucine zipper structural features, and the protein belongs to the MiT/TFE family. HGNC classifies it among the basic helix-loop-helix proteins. Heterozygous mutations in the gene cause auditory-pigmentary syndromes, such as Waardenburg syndrome type 2 and Tietz syndrome, which is reflected in the earlier gene names Waardenburg syndrome, type 2A and melanogenesis associated transcription factor. Mouse and rat orthologs are both designated Mitf.
MITF is a master regulator of melanocyte survival and differentiation, driving pigmentation genes such as TYR and TYRP1.
The transcription factor controls melanosome biogenesis, making it a central subject in studies of pigment cell organelle formation.
MITF activity depends on MTOR-mediated phosphorylation, linking amino acid availability and lysosomal stress to transcriptional output.
Heterozygous MITF mutations cause Waardenburg syndrome type 2 and Tietz syndrome, supporting research into these auditory-pigmentary conditions.
MITF is a transcription factor and master regulator of melanocyte survival, differentiation and melanosome biogenesis. It binds M-box and E-box DNA motifs in pigmentation gene promoters, including TYR and TYRP1, and also supports differentiation of mast cells, osteoclasts and retinal pigment epithelium.
MITF stands for melanocyte inducing transcription factor, previously microphthalmia-associated transcription factor and melanogenesis associated transcription factor. Aliases and earlier symbols include MI, bHLHe32, WS2A and WS2. The last two reflect its link to Waardenburg syndrome type 2.
Mouse and rat both have an ortholog named Mitf; check the datasheet of any product for its validated reactivity. In humans, heterozygous MITF mutations cause auditory-pigmentary syndromes, including Waardenburg syndrome type 2 and Tietz syndrome.
Other MiT/TFE family members, pigmentation enzymes and MTOR pathway proteins connected to MITF biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O75030; product specifications from Assay Genie datasheets.